🇺🇸 FDA
Pipeline program

Rasagiline Mesylate

TVP-1012/232

Approved small_molecule completed

Quick answer

Rasagiline Mesylate for Parkinson's Disease is a Approved program (small_molecule) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 8 ClinicalTrials.gov record(s).

Program details

Company
TEVA PHARMACEUTICAL INDUSTRIES LTD
Indication
Parkinson's Disease
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials